Mednet Logo
HomeQuestion

What is the role of upfront pembrolizumab in metastatic PD-L1 positive NSCLC presenting with SVC syndrome?

10
1 Answers
Mednet Member
Mednet Member
Medical Oncology · Albert Einstein College of Medicine at Montefiore Medical Center

This is a "trick question" as there are at least 3 difficult questions hidden here-

  1. Can systemic therapy replace the need for local therapy in urgent clinical situations traditionally calling for radiation?
  2. What is the best upfront treatment regimen for a patient with PD-L1 positive NSCLC?
  3. What is t...

Register or Sign In to see full answer